Legal Representation
Attorney
ANDREW S FLIOR
USPTO Deadlines
Application History
27 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 17, 2021 | MAB3 | E | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL |
| Feb 22, 2021 | EXPT | T | EXPARTE APPEAL TERMINATED |
| Feb 22, 2021 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL |
| Jan 11, 2021 | EXFB | T | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF |
| Oct 21, 2020 | CNCF | S | ACTION CONTINUING FINAL - COMPLETED |
| Oct 21, 2020 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED |
| Oct 21, 2020 | GEA1 | O | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED |
| Oct 1, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Oct 1, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sep 30, 2020 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB |
| Sep 30, 2020 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Sep 30, 2020 | EXPI | T | EX PARTE APPEAL-INSTITUTED |
| Sep 30, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Mar 31, 2020 | CNFR | R | FINAL REFUSAL WRITTEN |
| Mar 31, 2020 | GNFR | O | FINAL REFUSAL E-MAILED |
| Mar 31, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Mar 24, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Mar 24, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Mar 19, 2020 | ALIE | A | ASSIGNED TO LIE |
| Mar 12, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sep 12, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Sep 12, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Sep 12, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sep 9, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Mar 7, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Feb 28, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 9, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Therapeutic oils, salves, and balms, for topical use on the body and face; Therapeutic tinctures for topical use on the body and face; all of the forgoing goods containing CBD derived from hemp with a delta-9 THC concentration of not more than 0.3% on a dry weight basis
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"DOCTOR FORMULATED"
USPTO Documents
Loading USPTO documents...